Ortho-McNeil Janssen Scientific Affairs, LLC

Quick facts

Marketed products

• OROS MPH · Psychiatry / Neurology
  OROS MPH is an extended-release formulation of methylphenidate that provides sustained dopamine and norepinephrine reuptake inhibition throughout the day.
• OROS MPH Tablets · Psychiatry / Neurology
  OROS MPH is an extended-release formulation of methylphenidate that provides sustained dopamine and norepinephrine reuptake inhibition throughout the day.

Phase 3 pipeline

• tapentadol IR

Phase 1 pipeline

• Levofloxacin; Azithromycin

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Ortho-McNeil Janssen Scientific Affairs, LLC portfolio CI brief
• Ortho-McNeil Janssen Scientific Affairs, LLC pipeline updates RSS